Intermolecular antigen spreading occurs during the pre-clinical period of type 1 diabetes.

被引:0
|
作者
Brooks-Worrell, B
Gersuk, V
Greenbaum, C
Palmer, JP
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Virginia Mason Res Ctr, Seattle, WA 98101 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:91A / 91A
页数:1
相关论文
共 50 条
  • [41] Different onsets of type 1 diabetes.: Aged-based immunological and clinical differences.
    Fajardo, C
    Carmona, E
    Sanchez-Cuenca, JM
    Campos, V
    Carles, C
    Brazales, A
    Merino, F
    Piñón, F
    DIABETOLOGIA, 1999, 42 : A96 - A96
  • [42] C-peptide level and clinical remission in children with newly diagnosed Type 1 diabetes.
    Zmyslowska, A
    Wyka, K
    Mlynarski, W
    Mianowska, B
    Bodalski, J
    DIABETOLOGIA, 2003, 46 : A246 - A246
  • [43] Islet with kidney versus islet transplantation alone: Clinical experience in patients with type 1 diabetes.
    Maffi, Paola
    De Taddeo, Francesca
    Bertuzzi, Federico
    Nano, Rita
    Melzi, Raffaella
    Socci, Carlo
    Venturini, Massimo
    Del Maschio, Alessandro
    Piemonti, Lorenzo
    Secchi, Antonio
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 571 - 572
  • [44] Relationships between reduced heart rate variability and pre-clinical cardiovascular disease in patients with type 2 diabetes
    Cardoso, Claudia R. L.
    Moraes, Raphael A. M.
    Leite, Nathalie C.
    Salles, Gil F.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (01) : 110 - 117
  • [45] Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes Mellitus, Obesity and Diabetic Kidney Disease
    Bastos, Rosana M. C.
    Simplicio-Filho, Antonio
    Savio-Silva, Christian
    Oliveira, Luiz Felipe, V
    Cruz, Giuliano N. F.
    Sousa, Eliza H.
    Noronha, Irene L.
    Mangueira, Cristovao L. P.
    Quaglierini-Ribeiro, Heloisa
    Josefi-Rocha, Gleice R.
    Rangel, Erika B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [46] Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model
    Armstrong, Zachary B.
    Boughner, Derek R.
    Drangova, Maria
    Rogers, Kem A.
    CARDIOVASCULAR RESEARCH, 2011, 90 (01) : 165 - 170
  • [47] Immune and Metabolic Effects of Antigen Specific Immunotherapy Using Multiple b-Cell Peptides in Type 1 Diabetes.
    Petsiou, Asimina
    Vartholomatos, George
    Tsatsoulis, Agathocles
    Papadopoulos, George K.
    DIABETES, 2022, 71 (12) : E20 - E21
  • [48] Association of interferon-γ and interleukin 10 genotypes and serum levels with clinical remission in type 1 diabetes.
    Alizadeh, Behrooz
    Moghaddam, Pejman Hanifi
    Eerligh, Peter
    van der Slik, Arno
    Kharagjitsingh, Aan
    Kolb, Hubert
    Ronkainen, Matti
    Knip, Mikael
    Bonfanti, Riccardo
    Bonifacio, Ezio
    Devendra, Devasenan
    Wilkin, Terence
    Giphart, Marius
    Koeleman, Bobby
    Nolsoe, Runa
    Poulsen, Thomas Mandrup
    Schloot, Nanette
    Roep, Bart
    CLINICAL IMMUNOLOGY, 2006, 119 : S172 - S173
  • [49] Clinical Criteria Are Poor at Identifying Type 1 Diabetes. Should We Be Measuring Insulin Deficiency Directly?
    Shields, Beverley M.
    Shepherd, Maggie H.
    McDonald, Timothyj.
    Besser, Rachel E. J.
    Jones, Angus G.
    Raju, Neelima Bhupathi
    Wensley, Kirsty J.
    Githens-Mazer, Gayle
    Knight, Bridget A.
    Hattersley, Andrew T.
    DIABETES, 2010, 59 : A404 - A404
  • [50] Disturbed eating behaviors in adolescents with type 1 diabetes. How to screen for yellow flags in clinical practice?
    Eilander, Minke M. A.
    de Wit, Maartje
    Rotteveel, Joost
    Aanstoot, Henk Jan
    Bakker-van Waarde, Willie M.
    Houdijk, Euphemia C. A. M.
    Nuboer, Roos
    Winterdijk, Per
    Snoek, Frank J.
    PEDIATRIC DIABETES, 2017, 18 (05) : 376 - 383